Paper8980403
CAM 17.1--a new diagnostic marker in pancreatic cancer.
Gansauge F and 7 others. Br J Cancer, 1996. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. CAM 17.1--a new diagnostic marker in pancreatic cancer. Papers, record 8980403. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8980403
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Carcinoma | Major topic |
| Pancreatic Neoplasms | Major topic |
| Adult | |
| Aged | |
| Antibodies, Monoclonal | |
| Female | |
| Flow Cytometry | |
| Humans | |
| Immunohistochemistry | |
| Male | |
| Middle Aged | |
| Neoplasm Staging | |
| Pancreas | |
| Pancreatic Diseases | |
| Pancreatitis | |
| Sensitivity and Specificity | |
| Survival Analysis | |
| Tumor Cells, Cultured |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4008485 | Neutral and acidic species of human intestinal mucin. Evidence for different core peptides. | J Biol Chem | 1985 | https://conductscience.org/library/papers/4008485 | PubMed |
| 2 | 8071575 | The patterns of coexpression of tumor-associated antigens CA 19-9, TAG-72, and DU-PAN-2 in human pancreatic cancer. | Int J Pancreatol | 1994 | https://conductscience.org/library/papers/8071575 | PubMed |
| 3 | 3949243 | Carcinoembryonic antigen and recurrent colorectal cancer. | Gut | 1986 | https://conductscience.org/library/papers/3949243 | PubMed |
| 4 | 3456787 | Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer. | Br J Cancer | 1986 | https://conductscience.org/library/papers/3456787 | PubMed |
| 5 | 3459510 | The use of CA-50 radioimmunoassay in differentiating benign and malignant pancreatic disease. | Br J Cancer | 1986 | https://conductscience.org/library/papers/3459510 | PubMed |
| 6 | 3341547 | Reoperation directed by carcinoembryonic antigen level: the importance of a thorough preoperative evaluation. | Am J Surg | 1988 | https://conductscience.org/library/papers/3341547 | PubMed |
| 7 | 3163659 | Identification and partial characterization of a new pancreatic cancer-related serum glycoprotein by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and lectin blotting. | Gastroenterology | 1988 | https://conductscience.org/library/papers/3163659 | PubMed |
| 8 | 3390832 | Immunoglobulin G3 monoclonal antibody directed to Tn antigen (tumor-associated alpha-N-acetylgalactosaminyl epitope) that does not cross-react with blood group A antigen. | Cancer Res | 1988 | https://conductscience.org/library/papers/3390832 | PubMed |
| 9 | 3179943 | The evaluation of CA 19-9 antigen level in the early detection of pancreatic cancer. A prospective study of 866 patients. | Cancer | 1988 | https://conductscience.org/library/papers/3179943 | PubMed |
| 10 | 2481651 | Expression of TAG-72 in normal colon, transitional mucosa, and colon cancer. | Int J Cancer | 1989 | https://conductscience.org/library/papers/2481651 | PubMed |
| 11 | 2351483 | Purification and characterization of a peanut-agglutinin-binding pancreatic-cancer-related serum mucus glycoprotein. | Int J Cancer | 1990 | https://conductscience.org/library/papers/2351483 | PubMed |
| 12 | 2220731 | Comparative studies of DU-PAN-2, carcinoembryonic antigen, and CA19-9 in the serum and bile of patients with pancreatic and biliary tract diseases: evaluation of the influence of obstructive jaundice. | Am J Gastroenterol | 1990 | https://conductscience.org/library/papers/2220731 | PubMed |
| 13 | 4342354 | A histochemical study of mucins in normal and neoplastic human pancreatic tissue. | J Pathol | 1972 | https://conductscience.org/library/papers/4342354 | PubMed |
| 14 | 202385 | Purification, partial characterization, and clinical evaluation of a pancreatic oncofetal antigen. | Cancer Res | 1978 | https://conductscience.org/library/papers/202385 | PubMed |
| 15 | 77724 | Evaluation of the microleukocyte adherence inhibition assay as an immunodiagnostic test for pancreatic cancer. | Cancer Res | 1978 | https://conductscience.org/library/papers/77724 | PubMed |
| 16 | 709516 | Circulating carcinoembryonic antigen in pancreatic carcinoma. | Cancer | 1978 | https://conductscience.org/library/papers/709516 | PubMed |
| 17 | 7350842 | Sensitivity and specificity of serum ribonuclease in the diagnosis of pancreatic cancer. | Am J Surg | 1980 | https://conductscience.org/library/papers/7350842 | PubMed |
| 18 | 6163985 | Galactosyltransferase isoenzyme II in the detection of pancreatic cancer: comparison with radiologic, endoscopic, and serologic tests. | N Engl J Med | 1981 | https://conductscience.org/library/papers/6163985 | PubMed |
| 19 | 6193872 | Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. | Cancer Res | 1983 | https://conductscience.org/library/papers/6193872 | PubMed |
| 20 | 6206100 | Monoclonal antibody to cytokeratin for use in routine histopathology. | J Clin Pathol | 1984 | https://conductscience.org/library/papers/6206100 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38763973 | Tumor biomarkers for diagnosis, prognosis and targeted therapy. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/38763973 | PubMed |
| 38246662 | Cyfra 21.1: A Useful Tumour Marker in Pancreatic Ductal Adenocarcinoma: Cross-Sectional Study. | Cancer Control | 2024 | https://conductscience.org/library/papers/38246662 | PubMed |
| 34326612 | Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket? | World J Gastroenterol | 2021 | https://conductscience.org/library/papers/34326612 | PubMed |
| 32661873 | Immunotherapeutic strategies in pancreatic ductal adenocarcinoma (PDAC): current perspectives and future prospects. | Mol Biol Rep | 2020 | https://conductscience.org/library/papers/32661873 | PubMed |
| 24281109 | Serum tumor markers in pancreatic cancer-recent discoveries. | Cancers (Basel) | 2010 | https://conductscience.org/library/papers/24281109 | PubMed |
| 23331006 | The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates. | Curr Mol Med | 2013 | https://conductscience.org/library/papers/23331006 | PubMed |
| 22341255 | Pancreatic cancer screening. | Gastroenterol Clin North Am | 2012 | https://conductscience.org/library/papers/22341255 | PubMed |
| 21412497 | Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010. | World J Gastroenterol | 2011 | https://conductscience.org/library/papers/21412497 | PubMed |
| 21193998 | Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview. | J Cancer Res Clin Oncol | 2011 | https://conductscience.org/library/papers/21193998 | PubMed |
| 14960539 | The diagnostic dilemmas in discrimination between pancreatic carcinoma and chronic pancreatitis. | Gut | 2004 | https://conductscience.org/library/papers/14960539 | PubMed |
| 10323871 | Towards immunotherapy of pancreatic cancer. | Gut | 1999 | https://conductscience.org/library/papers/10323871 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8980403
GET https://conductscience.org/api/papers/v1/8980403/references?page=2